UiPath (PATH) Scheduled to Post Earnings on Wednesday

UiPath (NYSE:PATH) is scheduled to be releasing its earnings data after the market closes on Wednesday, May 29th. Analysts expect UiPath to post earnings of $0.11 per share for the quarter. UiPath has set its FY 2025 guidance at EPS and its Q1 2025 guidance at EPS.Persons interested in participating in the company’s earnings conference call can do so using this link.

UiPath (NYSE:PATH) last posted its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.10. The company had revenue of $405.25 million for the quarter, compared to the consensus estimate of $383.32 million. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. On average, analysts expect UiPath to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

UiPath Trading Down 0.3 %

PATH opened at $18.98 on Monday. The company has a market cap of $10.80 billion, a price-to-earnings ratio of -111.64 and a beta of 1.01. The company’s 50 day moving average is $20.63 and its 200 day moving average is $22.13. UiPath has a 12-month low of $13.30 and a 12-month high of $27.87.

Analysts Set New Price Targets

PATH has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. upgraded shares of UiPath from a “neutral” rating to an “overweight” rating and raised their target price for the stock from $22.00 to $28.00 in a research note on Thursday, March 14th. BMO Capital Markets raised their target price on shares of UiPath from $24.00 to $28.00 and gave the stock a “market perform” rating in a research note on Thursday, March 14th. Canaccord Genuity Group raised their target price on shares of UiPath from $27.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday, March 15th. Needham & Company LLC restated a “buy” rating and set a $30.00 target price on shares of UiPath in a research note on Wednesday, March 20th. Finally, DA Davidson raised their target price on shares of UiPath from $20.00 to $24.00 and gave the stock a “neutral” rating in a research note on Thursday, March 14th. Nine analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $27.41.

Insiders Place Their Bets

In other UiPath news, CFO Ashim Gupta sold 40,000 shares of the business’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $19.79, for a total value of $791,600.00. Following the completion of the transaction, the chief financial officer now directly owns 946,848 shares in the company, valued at $18,738,121.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Over the last ninety days, insiders sold 96,000 shares of company stock worth $2,023,440. 22.37% of the stock is owned by corporate insiders.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.